Fleming’s Sanofi-backed Project Aims to Increase Prescriber Adoption of Clinical Guidelines, Improve Patient Adherence to Statin Therapy
A UH College of Pharmacy researcher is exploring the factors resulting in sub-optimal prescribing of statin therapy to control high cholesterol with the aim of developing an educational webinar to improve prescriber implementation of the clinical guidelines and ultimately medication adherence by patients.
Backed by a one-year, $98,314 grant from Sanofi US, UHCOP Assistant Professor Marc L. Fleming, Ph.D., MPH, R.Ph., is working with fellow faculty member Susan M. Abughosh, Ph.D., and Pharmaceutical Health Outcomes and Policy doctoral candidate Mark Hatfield, M.S., to tackle the issue of underutilization – by virtue of underprescribing – of statin therapy.